NCT00375635Unknown不适用
Removal of Protein Bound Uremic Toxins in Chronic Hemodialysis Patients by Modified Plasma Separation and Adsorption Combined With Hemodialysis
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Blood pressure
研究概览
简要总结
The aim of this study is to examine removal of protein bound uremic substances by mFPSA in chronic hemodialysis patients. mFPSA is an extracorporal blood purification system developed for detoxification in acute liver failure by removal of protein bound as well as water soluble substances.
详细描述
Measurements of uremic protein bound substances before and after mFPSA and a preceding routine hemodialysis session.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Over the age of 18
- •Chronic hemodialysis dependence
排除标准
- •No present history of bleeding episodes
- •Cardiac diseases
结局指标
主要结局
Blood pressure
Safety serological parameters
Concentrations of protein bound uremic toxins
次要结局
- Bleeding episodes
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage MarkersInflammationNCT02240004Hospital Universitario Reina Sofia de Cordoba9
已完成
不适用
Investigation on solute removal efficiency under various treatment conditions in blood purification therapyChronic renal failureJPRN-UMIN000033547Saitama Medical University Integrated Medical Center7
已完成
不适用
Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated DialyzersEnd Stage Renal Disease (ESRD)NCT05610683Poitiers University Hospital41
尚未招募
2 期
Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic ToxinsEnd Stage Renal DiseaseChronic HemolysisNCT06595680Hospices Civils de Lyon12
已完成
不适用
Sodium Chloride and Protein-Bound Toxin Removal in HemodiafiltrationEnd-stage Renal DiseaseNCT01923961EXcorLab GmbH8